Churiwala Securities Pvt. Ltd. - leading and respected retail broking in India with over 3 decades of experience in creating wealth for investors with expertise in personalised investment planning in Equities / Portfolio Advisory for HNI & Retail clients.

Attention Investors

Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000. | Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors." | KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary." | ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

- EQUITY
  EQUITY
  PRICE
  
  Gainers & Losers
  
  Advances & Declines
  
  New Highs & Lows
  
  Index Movers
  
  Only Buyers/Sellers
  
  Out/Under Performers
- NEWS
  CORPORATE ACTIONS
  
  Announcements
  
  Book Closure
  
  Board Meetings
  
  Bonus Issues
  
  Rights Issues
  
  De-Listed Shares
  
  Market Turnover
  
  Change of Name
  
  Split of Face Value
- OTHER MARKETS
  FII Investments
  
  MF Investments
  
  ADR Prices
  
  World Indices
  
  Forex
  
  CORPORATE INFO
- VOLUME
  VOLUME
  Value & Volume Toppers
  
  Unusual Volume
  
  Bulk & Block Deals
  
  Sector Watch
- ANALYSIS
  ANALYSIS
  52 Week High Low
  
  Live Indices
  
  Exchange Holidays
  
  Index Constituents
  
  Historical Returns
  
  Circuit Breakers
- IPO
  IPO
  
  Forthcoming Issues
  
  Open Issues
  
  Closed Issues
  
  New Listing
  
  Basis of Allotment
  
  Draft Prospectus
  
  New Issue Monitor
  
  Best Performers
  
  Know IPO's / FAQ's

30 October 2024 10:41:00

Adani Ports

1400.75

(1.97%)

Asian Paints

2986.80

(-0.23%)

Axis Bank

1176.45

(-0.81%)

Bajaj Finance

6975.55

(-0.61%)

Bajaj Finserv

1745.15

(-1.28%)

Bharti Airtel

1629.00

(-0.48%)

HCL Technologi..

1859.90

(-0.67%)

HDFC Bank

1740.70

(-0.59%)

Hind. Unilever

2560.45

(0.44%)

ICICI Bank

1311.00

(-1.61%)

IndusInd Bank

1054.00

(1.52%)

Infosys

1821.60

(-0.93%)

ITC

490.40

(0.50%)

JSW Steel

964.55

(0.67%)

Kotak Mah. Ban..

1750.25

(-0.54%)

Larsen & Toubr..

3401.65

(0.61%)

M & M

2720.60

(-0.83%)

Maruti Suzuki

11200.65

(1.39%)

Nestle India

2288.00

(0.92%)

NTPC

410.00

(-0.55%)

Power Grid Cor..

323.25

(0.81%)

Reliance Indus..

1345.50

(0.49%)

St Bk of India

826.00

(-0.80%)

Sun Pharma.Ind..

1846.85

(-1.29%)

Tata Motors

845.90

(0.34%)

Tata Steel

150.30

(0.17%)

TCS

4091.75

(0.36%)

Tech Mahindra

1691.40

(-0.26%)

Titan Company

3270.25

(-0.41%)

UltraTech Cem.

11101.00

(-0.14%)

	Equity Analysis

	News Analysis

	Corporate Actions

	Other Market

	Company Profile

Share Holding Pattern

Glenmark Life Sciences Ltd			Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln


BSE Code:	543322	NSE Symbol:	GLS	P/E(TTM):	29.38

ISIN Demat:	INE03Q201024	Div & Yield %:	2.22	EPS(TTM):	34.56

Book Value(Rs):	207.1743448	Market Cap ( Cr.):	12439.72	Face Value(Rs):	2

Change Company

(

In Cr)

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
INCOME :
Sales Turnover	2283.21	2161.22	2123.21	1885.17	1537.31	886.42
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	2283.21	2161.22	2123.21	1885.17	1537.31	886.42
Other Income	12.04	28.96	14.70	0.81	11.99	0.44
Stock Adjustments	56.57	84.44	-41.32	70.70	4.64	301.59
Total Income	2351.82	2274.62	2096.59	1956.68	1553.94	1188.45
EXPENDITURE :
Raw Materials	1025.21	1068.56	977.96	948.17	668.66	633.56
Power & Fuel Cost	112.46	115.60	100.92	74.19	76.75	57.81
Employee Cost	258.16	180.18	168.72	149.13	142.28	106.28
Other Manufacturing Expenses	163.64	137.17	124.04	107.32	108.04	77.09
Selling and Administration Expenses	64.12	65.47	48.64	48.50	42.05	44.20
Miscellaneous Expenses	41.97	36.39	45.56	37.49	32.22	21.35
Less: Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	1665.54	1603.36	1465.83	1364.80	1069.99	940.29
Operating Profit	686.29	671.25	630.76	591.89	483.96	248.17
Interest	1.55	0.55	27.96	87.55	33.52	0.61
Gross Profit	684.74	670.70	602.80	504.34	450.44	247.56
Depreciation	53.45	42.09	37.88	33.39	29.37	19.26
Profit Before Tax	631.29	628.61	564.92	470.95	421.07	228.30
Tax	152.21	150.61	137.63	112.75	98.54	25.90
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	8.19	11.04	8.57	6.62	9.43	6.81
Reported Net Profit	470.89	466.96	418.72	351.58	313.10	195.59
Extraordinary Items	-0.53	-0.41	-0.55	-0.44	-0.91	-0.54
Adjusted Net Profit	471.42	467.37	419.27	352.02	314.01	196.13
Adjst. below Net Profit	-5.46	-0.29	-19.50	-0.53	0.47	-108.02
P & L Balance brought forward	1102.06	1021.35	750.79	399.73	86.17	-1.41
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	275.69	385.96	128.65	0.00	0.00	0.00
P & L Balance carried down	1291.80	1102.06	1021.35	750.79	399.73	86.17
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	1125.00	2100.00	1050.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	38.43	38.11	34.17	358.76	1597.44	997.92
Earnings Per Share(Adj)-Unit Curr	38.43	38.11	34.17	NA	NA	NA
Book Value-Unit Curr	190.35	174.51	167.66	768.11	2049.45	449.62